Extract

This study was intended to evaluate the efficacy, safety and tolerability of atacicept compared to placebo and to explore the neuroprotective effect of atacicept as assessed by OCT in subjects with ON as CIS. The study was randomized. Study medication was administered via subcutaneous (under the skin) injections.

Inclusion criteria

• Optic neuritis

Country

• Australia
• Belgium
• Canada
• Czech Republic
• France
• Germany
• Lebanon
• Spain
• Switzerland
• United Kingdom
• United States

Links

• ictrp
• nct